Clinical Trial Update: Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating [68Ga]Ga-PentixaFor PET imaging to assess adrenal gland function in hyperaldosteronism and hypercortisolism (Cushing's syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome
• Hyperaldosteronism

Drugs mentioned

• [68Ga]Ga-PentixaFor (pentixaFor radiopharmaceutical)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hyperaldosteronism, Hypercortisolism | Phase 2 | Status: RECRUITING